Effect of Vitamin D or activated Vitamin D on circulating 1,25-dihydroxyVitamin D concentrations: A systematic review and metaanalysis of randomized controlled trials

Clinical Chemistry

Volumn 61, Issue 12, 2015, Pages 1484-1494

  Zittermann, Armin ^a   Ernst, Jana B ^a   Birschmann, Ingvild ^a   Dittrich, Marcus ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; VITAMIN D; 1,25-DIHYDROXYVITAMIN D;

ARTICLE; CHEMILUMINESCENCE IMMUNOASSAY; CHRONIC KIDNEY DISEASE; HUMAN; META ANALYSIS; RADIORECEPTOR ASSAY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ADOLESCENT; ADULT; AGED; ANALOGS AND DERIVATIVES; BLOOD; DIET SUPPLEMENTATION; FEMALE; MALE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; STATISTICAL MODEL;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; CALCIUM; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN D;

EID: 84948702767     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2015.244913     Document Type: Article

References (40)

1. Zittermann A, Gummert JF. Nonclassical vitamin D action. Nutrients 2010;2:408-25.
2. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006;84:18-28.
3. Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium. Dietary reference intakes for calcium and vitamin D. Ross AC, Taylor CL, Yaktine AL, Del Valle HB, editors. Washington (DC): National Academies Press; 2011.
4. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 2008;168:1340-9.
5. Hollis BW. Assessment and interpretation of circulating 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in the clinical environment. Endocrinol Metab Clin North Am 2010;39:271-86.
6. Zittermann A, Kuhn J, Ernst JB, Becker T, Dreier J, Knabbe C, et al. 25-hydroxyvitamin d, 1,25-dihydroxyvitamin d and postoperative outcome in cardiac surgery. J Clin Endocrinol Metab 2015;100:72-80.
7. Zittermann A, Schleithoff SS, Götting C, Fuchs U, Kuhn J, Kleesiek K, et al. Calcitriol deficiency and 1-year mortality in cardiac transplant recipients. Transplantation 2009;87:118-24.
8. Zittermann A, Schleithoff SS, Frisch S, Götting C, Kuhn J, Koertke H, et al. Circulating calcitriol concentrations and total mortality. Clin Chem 2009;55:1163-70.
9. Nguyen HB, Eshete B, Lau KH, Sai A, Villarin M, Baylink D. Serum 1,25-dihydroxyvitamin D: an outcome prognosticator in human sepsis. PLoS One 2013;8:e64348.
10. Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 2014;1:CD007470.
11. Chowdhury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC, et al. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ. 348:g1903.
12. Zheng Z, Shi H, Jia J, Li D, Lin S. Vitamin D supplementation and mortality risk in chronic kidney disease: a meta-analysis of 20 observational studies. BMC Nephrol 2013;14:199.
13. Duranton F, Rodriguez-Ortiz ME, Duny Y, Rodriguez M, Daurès JP, Argilés A. Vitamin D treatment and mortality in chronic kidney disease: a systematic review and meta-analysis. Am J Nephrol 2013;37:239-48.
14. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic rev and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264-9.
15. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005;5:13.
16. Higgins JP, Thompson SG. Quantifying heterogeneity in a metaanalysis. Stat Med 2002;21:1539-58.
17. Macaskill P, Walter SD, Irwig L. A comparison of methods to detect publication bias in meta-analysis. Stat Med 2001;20:641-54.
18. Cochrane Community (beta). Cochrane handbook for systematic reviews of interventions. www.cochrane. org/handbook (Accessed March 2015).
19. R Core Team. R: a language and environment for statistical computing. http://www.R-project.org/ (Accessed March 2015).
20. Viechtbauer W. Conducting meta-analyses in R with the metaphor package. J Stat Software, 2010;36:1-48.
21. Sorva A, Välimäki M, Risteli J, Risteli L, Elfving S, Takkunen H, Tilvis R. Serum ionized calcium, intact PTH and novel markers of bone turnover in bedridden elderly patients. Eur J Clin Invest 1994;24:806-12.
22. Tuohimaa P. Vitamin D and aging. J Steroid Biochem Mol Biol 2009;114:78-84.
23. Redaelli CA, Wagner M, Tien YH, Mazzucchelli L, Stahel PF, Schilling MK, Dufour JF. 1 alpha, 25-Dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts. Hepatology 2001; 34:926.
24. Cantorna MT, Hullett DA, Redaelli C, Brandt CR, Humpal-Winter J, Sollinger HW, Deluca HF. 1,25-Dihydroxyvitamin D3 prolongs graft survival without compromising host resistance to infection or bone mineral density. Transplantation 1998;66:828.
25. Papapetrou PD. The interrelationship of serum 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D in pregnancy at term: a metaanalysis. Hormones 2010;9:136-44.
26. Zorbas YG, Kakuris KK, Deogenov VA, Yerullis KB. Phosphate homeostasis in healthy subjects during prolonged periodic and continuous hypokinesia. Clin Biochem 2007;40:460-6.
27. Scheld K, Zittermann A, Heer M, Herzog B, Mika C, Drummer C, Stehle P. Nitrogen metabolism and bone metabolism markers in healthy adults during 16 weeks of bed rest. Clin Chem 2001;47:1688-95.
28. Zittermann A, Scheld K, Stehle P. Seasonal variations in vitamin D status and calcium absorption do not influence bone turnover in young women. Eur J Clin Nutr 1998;52:501-6.
29. Moan J, Lagunova Z, Lindberg FA, Porojnicu AC. Seasonal variation of 1,25-dihydroxyvitamin D and its association with body mass index and age. J Steroid Biochem Mol Biol 2009;113:217-21.
30. Christensen MH, Lien EA, Hustad S, Almås B. Seasonal and age-related differences in serum 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and parathyroid hormone in patients from Western Norway. Scand J Clin Lab Invest 2010;70:281-6.
31. Michaëlsson K, Melhus H, Warensjö Lemming E, Wolk A, Byberg L. Long term calcium intake and rates of all cause and cardiovascular mortality: community based prospective longitudinal cohort study. BMJ 2013;346: f228.
32. Xiao Q, Murphy RA, Houston DK, Harris TB, Chow WH, Park Y. Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP diet and health study. JAMA Intern Med 2013;173:639-46.
33. Bolland MJ, Barber PA, Doughty RN, Mason B, Horne A, Ames R, et al. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 2008;336:262-6.
34. Bolland MJ, Avenell A, Baron JA, Grey A, MacLennan GS, Gamble GD, Reid IR. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 2010;341:c3691.
35. Giovannucci E. Dietary influences of 1,25(OH)2 vitamin D in relation to prostate cancer: a hypothesis. Cancer Causes Control 1998;9:567-82.
36. Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C. Evidence for persistent vitamin D 1-alphahydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment. Nephron Clin Pract 2008;110:c58-65.
37. Petkovich M, Jones G. CYP24A1 and kidney disease. Curr Opin Nephrol Hypertens 2011;20:337-44.
38. Yuan C, Kosewick J, He X, Kozak M, Wang S. Sensitive measurement of serum 1,25-dihydroxyvitamin D by liquid chromatography/tandem mass spectrometry after removing interference with immunoaffinity extraction. Rapid Commun Mass Spectrom 2011;25: 1241-9.
39. Hedman CJ, Wiebe DA, Dey S, Plath J, Kemnitz JW, Ziegler TE. Development of a sensitive LC/MS/MS method for vitamin D metabolites: 1,25 dihydroxyvitamin D2&3 measurement using a novel derivatization agent. J Chromatogr B Analyt Technol Biomed Life Sci. 2014;953-954:62-7.
40. DiaSorin. 1,25 Dihydroxyvitamin D. http://www.diasorin.com/sites/default/files/allegati-prodotti/brochure-vitamin-d-pag-sing-0.pdf (Accessed October 2015).